Activity value 75International Buyer&Supplier,Last transaction date:
2026-06-24
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for cheplapharm arzeimittel gmbh from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 44 transactions, with a transaction quantity of 220731.7 and a transaction weight of 20825.
Product description
DRUGS AND MEDICINE: MEDICINE FOR CARDIAC USE: DILATREND TABLETS 12.5MG (PK) GENERIC NAME (CARVEDILOL) BATCH NO: M2125 MFG 23-02-2026 EXP 29-02-2028 QTY 25KGS (WE HAVE CLAIM EXEMPTION I.E 5TH SCHEDULE PART II S.NO 20(I) AS THE SAID GENERIC NOT FOUND IN TABLE C DRUGS SERIAL # 20 WE HAVE ATTACHED SRO 567 AGAINST CLAIM THE
Expand
Hs code
30049099000
Product tags
mater,cap,orlistat,mg ca
Product description
15580 EA XENICAL CAP 120MG X 21 PH (MATERIAL NO. 000000000021163851) (120 MG CAPSULE) (ORLISTAT) (11 PALLETS LOADED INTO 2 X RAP AND 1 RKN CONTAINER)
Expand
Suppliers
cheplapharm arzeimittel gmbh
Buyers
тов дельта медікел
POLs
——
PODs
київська митниця
Supply area
Other
Purchas area
Ukraine
Weight
398.91kg
Amount
119493.52
Hs code
3004200000
Product tags
——
Product description
ЛІКАРСЬКІ ЗАСОБИ ДЛЯ ЛЮДЕЙ ЩО МІСТЯТЬ АНТИБІОТИКИ РАЗФАСОВАНІ ДЛЯ РОЗДРІБНОЇ ТОРГІВЛІ ЮНІДОКС СОЛЮТАБR ТАБЛЕТКИ ЩО ДИСПЕРГУЮТЬСЯ ПО 100 МГ ПО 10 ТАБЛЕТОК У БЛІСТЕРІ ПО 1 БЛІСТЕРУ У КАРТОННІЙ КОРОБЦІ 20040 УП СЕРІЯ 22J0606 16 680 УП СЕРІЯ 22J0706 3 360 УП ВИРОБНИК ASTELLAS PHARMA EUROPE B V НІДЕРЛАНДИ
Expand
Product description
XELODA, S/M, S/M MEDICAMENTO / PRINCIPIO ACTIVO:CAPECITABINA SE UTILIZA PARA TRATAMIENTO DEL CANCER DE MAMA,GASTRICO,COLO,COLORRECTAL XELODA 500 MG X 120 TAB (E) PEC3617002 / 0000063990, 2511068-FV06.28 - 30/06/2028 ,CREDITO A 30 DIAS DE FECHA FACTURA
Expand
Suppliers
cheplapharm arzeimittel gmbh
Buyers
тов дельта медікел
POLs
——
PODs
київська митниця
Supply area
Other
Purchas area
Ukraine
Weight
797.41kg
Amount
237924.18
Hs code
3004200000
Product tags
——
Product description
ЛІКАРСЬКІ ЗАСОБИ ДЛЯ ЛЮДЕЙ ЩО МІСТЯТЬ АНТИБІОТИКИ РАЗФАСОВАНІ ДЛЯ РОЗ ДРІБНОЇ ТОРГІВЛІ ЮНІДОКС СОЛЮТАБR ТАБЛЕТКИ ЩО ДИСПЕРГУЮТЬСЯ ПО 100 МГ ПО 10 ТАБЛЕТОК У БЛІСТЕРІ ПО 1 БЛІСТЕРУ У КАРТОННІЙ КОРОБЦІ 40060УП BATCH 22J0506 15 340 PACKS BATCH 22J0606 24 720 PACKS ВИРОБНИК ASTELLAS PHARMA EUROPE B V НІДЕРЛАНДИ
Expand
Trade date
2026/05/18
B/L No.
——
Suppliers
cheplapharm arzeimittel gmbh
Buyers
radiant business consortium ltd.
cheplapharm arzeimittel gmbh is International Buyer&Supplier,
and primarily engages in the import and export business of products such as medicine,bat,flemoxin soluta.
According to the 52wmb.com global trade database, as of 2026-06-24, the company has completed 843 international trades,
with its main trading regions covering russia,philippines,colombia etc.
The core products include HS30049099000,HS30049099,HS3004100005 etc,
often transported via berlin,port leipzig, port amsterdam etc,
and its main trading partners are zuellig pharma pte.ltd.,amarey nova medical s.a.,ооо чеплафарм.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on cheplapharm arzeimittel gmbh is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.